Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 35
Titolo Data di pubblicazione Autori File
PROGNOSTIC ROLE OF TUMOR INFILTRATING LYMPHOCITES (TILS) IN EPITHELIOID PLEURAL MESOTHELIOMA 1-gen-2017 BONAZZA, DEBORAHBOTTIN, CRISTINAGENERALI, DANIELEGIUDICI, FABIOLASANTON, DanielaSOBHANI, NAVIDTOFANELLI, MARGHERITAZANCONATI, FABRIZIO
Bevacizumab in small cell lung cancer 1-gen-2017 Roviello, GiandomenicoSobhani, NavidGenerali, Daniele
Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma 1-gen-2017 SOBHANI, NAVIDCorona, Silvia PZANCONATI, FABRIZIOGENERALI, DANIELE
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5) 1-gen-2017 Sobhani, N.Ianza, A.Roviello, G.Mustacchi, G.Bortul, M.Zanconati, F.Generali, D. +
PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy 1-gen-2017 Sobhani, NavidGenerali, DanieleRoviello, Giandomenico
Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma 1-gen-2017 SOBHANI, NAVIDROVIELLO, GIANDOMENICOCorona, S. P.IANZA, ANNAZANCONATI, FABRIZIOGENERALI, DANIELE
Advances in systemic therapy for malignant mesothelioma: Future perspectives 1-gen-2017 Sobhani, NavidCorona, Silvia PaolaBonazza, DeborahIanza, AnnaRoviello, GiandomenicoCortale, MaurizioGuglielmi, AlessandraZanconati, FabrizioGenerali, Daniele +
Advances in systemic therapy for metastatic breast cancer: future perspectives 1-gen-2017 Corona, S. P.SOBHANI, NAVIDIANZA, ANNAROVIELLO, GIANDOMENICOMUSTACCHI, GIORGIOBORTUL, MARINAZANCONATI, FABRIZIOGENERALI, DANIELE
Lenvatinib for the treatment of renal cell carcinoma 1-gen-2018 Roviello G.Corona S.Generali D.Ianza A.Sobhani N. +
The prognostic value of PI3K mutational status in breast cancer: A meta-analysis 1-gen-2018 Sobhani, NavidRoviello, GiandomenicoCORONA, SILVIAIanza, AnnaBortul, MarinaZanconati, FabrizioGenerali, Daniele +
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives? 1-gen-2018 Navid SobhaniDaniele GeneraliFabrizio ZanconatiMarina BortulBruna Scaggiante
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer 1-gen-2018 Sobhani, NavidGenerali, DanieleRoviello, Giandomenico +
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer 1-gen-2018 Navid SobhaniDaniele GeneraliFabrizio ZanconatiMarina BortulBruna Scaggiante
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer 1-gen-2018 Sobhani, NavidIanza, AnnaRoviello, GiandomenicoGiudici, FabiolaBortul, MarinaZanconati, FabrizioBottin, CristinaGenerali, Daniele +
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma 1-gen-2019 Sobhani NRoviello GIanza ABonazza DZanconati FGiudici FBottin CCorona SPRizzardi CCortale MConfalonieri MGenerali D. +
Avelumab in gastric cancer 1-gen-2019 Roviello G.Generali D.De Manzini N.Sobhani N. +
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma 1-gen-2019 Sobhani, NavidRoviello, GiandomenicoBonazza, DeborahBottin, CristinaGiudici, FabiolaZanconati, FabrizioDe Manzini, NicoloGenerali, Daniele +
The combination of bevacizumab with chemotherapy is more beneficial in the metastatic setting rather than in the adjuvant setting for the treatment of HER2-negative breast cancer—a commentary on the E5103 randomized phase III clinical study 1-gen-2019 Roviello G.Generali D.Sobhani N.
Updates on the CDK4/6 inhibitory strategy and combinations in breast cancer 1-gen-2019 Sobhani N.Roviello G.Bernocchi O.Generali D. +
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer 1-gen-2019 Roviello G.Generali D.Sobhani N. +
Mostrati risultati da 1 a 20 di 35
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile